Orlando Agrippa, Draper & Dash - slides from Journeys of Health-Tech Innovation: Products to Market

1. HTI LABS- Journeys of Health-Tech Innovation

2. Health Overview

3. just over £116bn

4. £1 billion
in new technology over the next 5 years to provide safe and prompt care
£10M in expanding the Healthcare Innovation Test Bed
programme – facilitates partnerships between industry and NHS by
testing combinations of new digital technologies and innovations in
NHS services.

5. £22 billion
savings plan missed due to £8bn injection
70+ year old healthcare system

6. Company Overview

10. Products and Technology

11. www.draperanddash.com
Confid
e
n tial Information Memorandum
9
Draper &Dash blends industryexpertise and advanced technologyto deliver accurate perspectives and in-depth analytics
on business dynamics. Actionable insights, powered bysuperior information assets, are tuned to each clients’ precise
requirements. The company’s products and services can be divided into the following two streams.
Healthcare Data Analytics
• Asuite of 22+ Clinical, Operational and Corporate Quality, Safetyand Effici ency (QSE) heal thcar e dataanalytics
applications
• HealthCost patient-level activity-based costing
• Oxygen Mobile Application Suite makes the power of sophisticated analytics accessible on mobile platforms
Professional Services
• The D&DPulse asolutions-based deliverymodel is akeymethodologyfor ensuring measurable rapid “Time to Value”
and high Returns on Investment (ROI)for all D&Dapplications
• Created to enable the rapid deployment of D&Dapps, the model has been designed to be veryresource-light with small
workgroup improvement teams
Products &
Technology

12. www.draperanddash.com
Confid
e
n tial Information Memorandum
10
V2 Applications are asuite of Clinical, Operational and Corporate Quality, Safetyand Effici ency (QSE) Busi ness Int elligence
applications with an elegant and effic
i
ent dat avi sual izat ion user int erface.
• Draper &Dash’s 22+ effici ent pr oven applications are used throughout the NHSin top tier hospitals, as well as major
institutions in Australia, and Ireland. USdeployments are under contract negotiation.
• V2 is the second iteration of Draper &Dash’s best of breed applications,
V2
Applications

13. www.draperanddash.com
Confid
e
n tial Information Memorandum
42
• Allows hospitals to focus on letting themto make informed
decisions on howto drive utilisation, qualityand safetyimprove-
ments within operating rooms
• Shows the surgeons, nurses and operation managers the cur-
rent state of playwithin each of the operating rooms, refreshed
in real time or on adailybasis
• The app gives visualisation of total utilisation, knife to skin times
and cancellations daily
• Clinicians can drill down to patient level
• The theatres teamcan see which theatres are underutilised and
investigate down to patient level of each procedure
Operating
Theatres
• The app allows users to review:
o Theatre Operations
o Theatre Utilization
o Theatre Cancellations
o Theatres Sessions
o Arrivals and Transfer
o High risk patients types in theatre
o Turnaround
o Late starts of operations
o Knife to Skin to Closure
o Theatre throughput byconsultant
o All dimensions byward, consultants, speciality
and Directorates
o Anaesthetics
o Recovery
• All of these can be reviewed and the datacut by
operating theatre, clinician or specialtyto identifytrends
or problemareas

14. www.draperanddash.com
Confid
e
n tial Information Memorandum
14
• Allows users to focus on driving qualityand safetyimprovements to their services and
reduce the number of avoidable deaths occurring
• Provides clinicians with dailyvisibilityof crude mortalities byward, specialty, diagnosis
groups and other dimensions of high volume mortalities
• Provides governance insight within each of the specialties, which is refreshed daily
frompatient level data, giving clinicians and executives visibilityof safetychallenges,
mortalities and trends in patient outcomes
• Users can drill down to patient level
• It supports rich discussions at monthlymortalityand morbiditymeetings, where clinical
teams can see which ward, specialtyor facilityis potentiallyunsafe or experiencing
higher levels of patient safetychallenges
• The app analyses:
o Performance byCrude Mortality&Mortalityrate
Mortality&
Outcomes
o Mortality&Outcome ActivitybySpeciality&Facility
o Diagnosis Depth
o Patients who have been re-admitted before dying
o Patients who die in various long termcondition groups
o Palliative Care
o Patient level validation
o Other keymeasures and dimensions
o All dimensions byward, consultants, specialityand Directorates
o DNA
o Cancellations
• This helps to identifyunnecessarydeaths, whether it’s aclinical challenge or seasonality

17. Mobile Trend

18. www.draperanddash.com
Confid
e
n tial Information Memorandum
21
Over 40 hospitals in the UK, Australia, and Ireland, including the UK’s National Health
System(NHS), have adopted Draper and Dash products since their introduction in late
2013. With the fall release of its mobile Oxygen Guided Analytics products, as well
as additional product suites, D&Dexpects to continue to expand market penetration
within its existing territories, as well as enter the USbefore year end, leading to FY2015
revenue more than triple that of 2013.
Customer
Base

19. www.draperanddash.com
Confid
e
n tial Information Memorandum
22
About the Client
As one of Victoria’s leading public teaching hospitals, The
Royal Melbourne Hospital (RMH)has set acourse to harness
analytic capabilities and use analysis and evidence-based
research to improve outcomes for patients.
Challenges
The 2014 Commonwealth Fund report ranks the UKfirs t
overall for healthcare, scoring it highlyfor its qualityof care,
effic
i
ency and low cost at the poi nt of ser vice –something
we recognised and was keen to push through in our own
performance. Working with the support of Draper &Dash
(D&D), aUK-based healthcare specialist analytics providers,
we enlisted D&D’s support and sawthe implementation of
an enterprise-wide suite of healthcare QlikViewapplications
covering everything fromemergencydepartment waits, to
readmissions and patient safety.
D&D Approach & Support
An enterprisewidehealthcaresolution was deployed, focused
on providing visibilityaround inpatients, readmissions, ED
waits and mortality. This was just the beginning of our road
to improvement, with D&D’s ongoing support and analysis,
implementing best practice fromthe NHSand use of effe
c
t ive
turnaround strategies we have been able to identify$7 million
in effic
i
ency savi ngs.
Case
Study1
Outcomes
Through the planning of simple changes we have identifie
d
substantial additional revenue. With the second highest
average length of stayin Victoria, we recognised there was
scope to decrease. Taking best practice fromthe NHS, we
focused on converting inpatient stays to daycase surgeries
through using the British Association of DaySurgery(BADS)
recommendations. Applying these principles, an additional
unadjusted daycase revenue of $842,960 was identifie
d
for
2014/15 bymoving 161 short stayinpatients to daycases,
across 20 procedures. In addition to increased revenue, D&D
supported our service improvement teamto highlight the
potential benefitof extrabed days to facilitate reducing waiting
lists and further fina nci al savi ngs. The addi tional benef itst o
patients for moving short stayinpatients to daycases has
trulydriven forward this change in the organisation –reducing
waiting times frombetter utilisation of hospital capacity,
reducing the risk of cancellation through switching to daycase,
speedier recoveryfor the patient and better outcomes with a
reduced risk for hospital acquired infections.
Potential Additional Day Case Revenue (2014/15 YTD)

20. Q+A